BWX TECHNOLOGIES, INC. (BWXT) /
The cash flow of BWX TECHNOLOGIES, INC. over the past 10 years
Chart BWX TECHNOLOGIES, INC.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, BWX TECHNOLOGIES, INC.'s operating cash flow was $479.85M and its capital expenditures $184.56M, leaving free cash flow of $295.29M. Free cash flow was above zero in 9 of the 10 years shown. It ranged from -$58.59M in fiscal 2020 to $295.29M in fiscal 2025. Capital expenditures were highest in fiscal 2021, at $311.05M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $479.85M | $184.56M | $295.29M |
| 2024ended Dec 31, 2024 | $408.43M | $153.65M | $254.78M |
| 2023ended Dec 31, 2023 | $363.7M | $151.29M | $212.41M |
| 2022ended Dec 31, 2022 | $244.7M | $198.31M | $46.39M |
| 2021ended Dec 31, 2021 | $386.03M | $311.05M | $74.97M |
| 2020ended Dec 31, 2020 | $196.44M | $255.03M | -$58.59M |
| 2019ended Dec 31, 2019 | $279.37M | $182.12M | $97.24M |
| 2018ended Dec 31, 2018 | $169.29M | $109.34M | $59.95M |
| 2017ended Dec 31, 2017 | $221.96M | $96.88M | $125.08M |
| 2016ended Dec 31, 2016 | $239.91M | $52.63M | $187.27M |
Fiscal years as BWX TECHNOLOGIES, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on BWX TECHNOLOGIES, INC.
- The revenue of BWX TECHNOLOGIES, INC.
- The profitability of BWX TECHNOLOGIES, INC.
- The debt of BWX TECHNOLOGIES, INC.
- The dividends of BWX TECHNOLOGIES, INC.
- All of BWX TECHNOLOGIES, INC.'s financials, charted
Companies of a similar size
- AVTRAvantor, Inc.
- CHYMChime Financial, Inc.
- JKHYJACK HENRY & ASSOCIATES, INC.
- HRLHORMEL FOODS CORPORATION
- DOCNDigitalOcean Holdings, Inc.
Not investment advice. This page shows what BWX TECHNOLOGIES, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.